Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

CareDx

Adaptive Biotechnologies

Veracyte

Ionis Pharma

Nurix Therapeutics, Inc

Intellia Therapeutics

10X Genomics

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

ARK Innovation ETF

Amplify Lithium & Battery Technology ETF

Proshares Bitcoin & Ether Strategy Etf

ProShares Bitcoin Strategy ETF

Global X Blockchain ETF

Amplify Transformational Data Sharing ETF

Bitwise Bitcoin And Ether Equal Weight Strategy Etf

VanEck Vectors Digital Transformation ETF

Dimensional US Core Equity 2 ETF

Global X Funds - Global X E-commerce ETF

Global X Telemedicine & Digital Health ETF

Vaneck Ethereum Strategy Etf

Amplify Emerging Markets FinTech ETF

AB Disruptors ETF

First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund

The Goldman Sachs Future Tech Leaders Equity ETF

ROBO Global Healthcare Technology and Innovation ETF

Amplify Online Retail ETF

iShares Genomics Immunology and Healthcare ETF

Pacer Benchmark Industrial Real Estate SCTR ETF

JPMorgan Equity Premium Income ETF

Global X Lithium & Battery Tech ETF

Proshares Online Retail ETF

Global X PropTech ETF

Good Morning, VettaFi Voices! Disruptive innovation is a popular topic, and it encompasses everything from bitcoin and cryptocurrency to electric vehicles to artificial intelligence.

VettaFi Voices On: Accessing Disruptive Innovation

iShares U.S. Regional Banks ETF

iShares U.S. Home Construction ETF

Amplify Alternative Harvest ETF

Wall Street wrapped up the best week of 2023 to start November driven by increased investor confidence, buoyed by solid corporate earnings and signals that the Fed's aggressive interest rate hiking campaign might be nearing an end.

5 Sector ETFs at the Forefront of the Market Rally Last Week

ARK Industrial Innovation ETF

On this episode of ETF Prime, host Nate Geraci speaks with a pair of individuals discussing several different ETF-related topics. His guests include VettaFi's Lara Crigger, who discusses ARK Invest's future, Fiedlity's share class filing, and more.

ETF Prime: Crigger on ARK Invest's Future and More 

iShares Nasdaq Biotechnology ETF

SPDR S&P Biotech ETF

The best biotech ETFs allow investors a diversified way to play the volatile biotechnology industry. Here's how to find them.

How to Find the Best Biotech ETFs

Loncar Cancer Immunotherapy ETF

iShares MSCI Israel ETF

VanEck Vectors Israel ETF

Subversive Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Invesco WilderHill Clean Energy ETF

ALPS Medical Breakthroughs ETF

Invesco Solar ETF

Strategic Crispr & Gene Editing Technology ETF

After a downbeat September, October too remained volatile for Wall Street due to higher rates.

5 ETF Areas That Spooked Investors in October

Beam Therapeutics

bluebird bio

Pfizer

Vertex Pharmaceuticals

In September, Cathie Wood and Ark Invest bought shares of Beam Therapeutics more than a dozen times. Beam Therapeutics is a clinical-stage drugmaker with a unique approach to developing new gene therapies.

Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?

The ARK Genomic Revolution ETF is a $2bn actively managed ETF that focuses on companies leveraging genomics in their products and services. Genomic-based applications have the potential to revolutionize healthcare and address modern-day illnesses. ARKG is an expensive and risky offering with high costs, high valuations, an elevated volatility profile and heightened sensitivity to the broader markets.

ARKG ETF: An Enticing Play, But Risks Galore

iShares MSCI Emerging Markets ETF

iShares Robotics & Artificial Intelligence Multisector ETF

Growth stocks have rebounded this year after a broad sell-off in 2022. Growth-oriented exchange-traded funds, or ETFs, are an easy and straightforward way to take advantage of this emerging trend.

3 Top Growth ETFs to Buy Right Now

Moderna

Superstar investor Cathie Wood bought shares of Moderna over a period of two days this week. The biotech company may become a respiratory vaccine giant -- with coronavirus, RSV, and flu vaccines -- in just a few years.

Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?

VanEck Vectors Biotech ETF

Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.

Is Now the Right Time to Embrace Biotech ETFs?

Cathie Wood is swinging for the fences with several gene-editing stocks. She's also making shrewd short-term trades with these stocks.

Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy

ACADIA Pharma

Agios Pharmaceuticals

Amgen

BioMarin Pharmaceutical

Exact Sciences

Exelixis

First Trust NYSE Arca Biotechnology Index Fund

FibroGen

Gilead Sciences

IQVIA Hlds

Madrigal Pharmaceuticals

Pacific Biosciences of California

Regeneron Pharmaceuticals

Seagen

Teladoc

TG Therapeutics

Here are the five best biotech ETFs to invest in right now.

Investing in Biotech ETFs

The cancer treatment/immuno-oncology market is expansive and ripe with potential for long-term healthcare investors. Predictably, there are significant implications for biotechnology and genomics companies.

ARKG: Smart Idea for Smart Advancements in Cancer Treatment

Biotech comes with a great many positive externalities for society, and can be a big positive for portfolios right now.

Biotech ETFs' Performance Deserves A Look

Biotechnology and genomics equities are showing modest signs of life this year following dismal showings in 2022. The good news for long-term investors is that there could well be much more to come, particularly in the genomics arena.

Genomics Outlook for Disruption Is Rising

Cathie Wood's ARKG provides investors with an opportunity to take advantage of the billion-dollar genomics market. However, it has performed poorly compared to XLV's higher-quality holdings in a period where the Fed has aggressively hiked interest rates.

ARKG: A Probable Window Of Opportunity, Depending On Banks And The Fed

Global X Artificial Intelligence & Technology ETF

Alerian MLP ETF

ARK Web x.0 ETF

Global X Robotics & Artificial Intelligence ETF

First Trust NASDAQ Global Auto Index Fund

ROBO Global Robotics and Automation ETF

First Trust Nasdaq Artificial Intelligence & Robotics ETF

Invesco Alerian Galaxy Crypto Economy ETF

ALPS Sector Dividend Dogs ETF

Robo Global Artificial Intelligence ETF

A decade ago, when the ROBO Global Robotics & Automation Index ETF (ROBO) launched, the U.S. thematic ETF market was nascent, with only a handful of products and minimal assets. However, at the end of 2021, there was approximately $130 billion in assets invested, per Global X.

Thematic Index Lineup Joins VettaFi and the Future Is Bright

Under most circumstances, stock picking is difficult, and that difficulty level is ratcheted higher in the disruptive technology space. That's certainly true of genomics investing where fortunes are burned and minted on the back of clinical trial success.

This Stock Could Propel Genomics ETFs

Experienced healthcare investors know several important facts regarding large-cap, blue-chip biopharma companies. First, these firms enjoy a limited amount of time when their blockbuster drugs corner a specific niche.

Innovation Is Crucial to Healthcare Sector Long-Term Growth

Healthcare is an epicenter of innovation, and some exchange traded funds put investors front and center when it comes to accessing that theme. Count the ARK Genomic Revolution ETF (ARKG) as one of the most relevant members of that conversation.

Outlook for Healthcare Innovation Is Brightening

Global X Genomics & Biotechnology ETF

Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

Axcelis Technologies

Amazon

Celsius Holdings

Alphabet

QUALCOMM

Target

United Rentals

Veeva Systems

These diversified growth stocks could add rocket fuel to your long-term investment portfolio.

10 Best Stocks to Buy in March 2023

Genomics is one of the epicenters of healthcare innovation and that will remain true for years to come. For investors looking to tap into that theme, it pays to examine some of the catalysts that will facilitate long-term upside for genomics equities.

These Segments Could Power ARK Genomics ETF

The healthcare sector has long been a mecca of innovation and one of the key elements in that theme is the evolution of genetics. Not only does that profound effects on patient outcomes, but there are significant implications for investors as well.

Bright Future for this Disruptive Healthcare ETF

It's hard to imagine it now, but at the turn of the millennium, the big advancement in technology was not the latest phone app, it was the Human Genome Project. Since then, genetics advancements are now powering health and biotech industries, with the latest upgrades coming in DNA synthesis.

Eye DNA Synthesis Advances in Active Biotech ETF ARKG

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)